PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,940 | +80.1% | 30,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $4,965 | -83.0% | 30,000 | 0.0% | 0.00% | -80.0% |
Q1 2023 | $29,280 | -6.2% | 30,000 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $31,200 | -10.9% | 30,000 | 0.0% | 0.01% | -16.7% |
Q3 2022 | $35,000 | -37.5% | 30,000 | 0.0% | 0.01% | -33.3% |
Q2 2022 | $56,000 | -38.5% | 30,000 | 0.0% | 0.01% | -25.0% |
Q1 2022 | $91,000 | -19.5% | 30,000 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $113,000 | -27.1% | 30,000 | 0.0% | 0.01% | -33.3% |
Q3 2021 | $155,000 | +34.8% | 30,000 | 0.0% | 0.02% | +40.0% |
Q2 2021 | $115,000 | +49.4% | 30,000 | 0.0% | 0.02% | +36.4% |
Q1 2021 | $77,000 | +2.7% | 30,000 | 0.0% | 0.01% | -8.3% |
Q4 2020 | $75,000 | +21.0% | 30,000 | 0.0% | 0.01% | +9.1% |
Q3 2020 | $62,000 | -33.3% | 30,000 | 0.0% | 0.01% | -35.3% |
Q2 2020 | $93,000 | +36.8% | 30,000 | 0.0% | 0.02% | +6.2% |
Q1 2020 | $68,000 | -37.6% | 30,000 | 0.0% | 0.02% | -15.8% |
Q4 2019 | $109,000 | +6.9% | 30,000 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $102,000 | – | 30,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
CM Management, LLC | 649,400 | $193,521 | 0.20% |
BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |